Literature DB >> 17659973

Gamma knife radiosurgery for choroidal hemangioma.

Doo-Sik Kong1, Jung-Il Lee, Se-Woong Kang.   

Abstract

PURPOSE: To determine the feasibility of gamma knife radiosurgery (GKS) in the treatment of symptomatic choroidal hemangioma (CH).
DESIGN: Observational case series.
METHODS: Three patients who had CH were treated with GKS. Ophthalmologic examinations revealed submacular fluid collection and retinal detachment associated with CH in all cases. GKS was performed as an initial treatment in two cases of circumscribed CH and as secondary treatment after failure of photocoagulation in the other diffuse CH.
RESULTS: The follow-up period ranged from 18 to 36 months, and visual acuity of the affected eyes was improved in all cases. The volume of CHs and submacular fluid collection were decreased. There were no adverse effects of radiation such as retinopathy or optic neuropathy.
CONCLUSIONS: GKS may be a useful alternative treatment for symptomatic CHs that are difficult to be managed with a standard therapeutic option such as photocoagulation.

Entities:  

Mesh:

Year:  2007        PMID: 17659973     DOI: 10.1016/j.ajo.2007.03.052

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  4 in total

Review 1.  Vascular tumors of the choroid and retina.

Authors:  P Mahesh Shanmugam; Rajesh Ramanjulu
Journal:  Indian J Ophthalmol       Date:  2015-02       Impact factor: 1.848

2.  Radiation therapy for exudative choroidal hemangioma.

Authors:  Paul T Finger
Journal:  Indian J Ophthalmol       Date:  2019-05       Impact factor: 1.848

Review 3.  Circumscribed Choroidal Hemangioma.

Authors:  Saeed Karimi; Ramin Nourinia; Arman Mashayekhi
Journal:  J Ophthalmic Vis Res       Date:  2015 Jul-Sep

Review 4.  Circumscribed choroidal hemangioma: An overview of clinical manifestation, diagnosis and management.

Authors:  Mrittika Sen; Santosh G Honavar
Journal:  Indian J Ophthalmol       Date:  2019-12       Impact factor: 1.848

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.